Transaction and Valuation

When SPACs Come Irresistibly Close – How Asia Stock Exchanges’ Card Up Their Sleeves?

SPACs may become more popular than traditional IPOs in the near future. Both Hong Kong and Singapore are prompted to introduce SPACs in their capital markets. 

COVID-19 – Valuation and Market Update (30 June)

The first half of 2020 has been full of unexpected events.  COVID-19 has already infected more than 13 million people worldwide, and social distance measures have brought global economic activities to a halt. Other events, such as the oil price crash and the new wave of secondary listing in Hong Kong, further made the market to be extremely volatile. Given the fluid nature of the pandemic, different stakeholders and practitioners in the business world are facing unprecedented challenges. Various regulators and industry organisations, including SFC, HKEX and IFRS Foundation hence published an amount of new guidance and technical notes, aiming to expand the regulatory focus amid economic uncertainties and market volatilities.

Valuation considerations amid the COVID-19 Crisis

As the COVID-19 outbreak accelerates, how to deal with valuation uncertainty is one of the most concerning questions. At the same time, the International Valuation Standards (IVS) did not forbid valuations with uncertainties to be performed. 

Desktop Valuations - Solution to travel restrictions due to the Coronavirus?

Since late January 2020, the outbreak of the novel coronavirus has grasped the headlines of various media outlets across the globe. Big businesses in the PRC are either temporarily shutting down stores or advising staff to work from home. As a range of PRC companies listed in Hong Kong have been severely affected by the virus, on 30 January 2020, the Securities and Futures Commission (SFC) and the Stock Exchange of Hong Kong Limited (HKEX) released a joint statement to remind all Hong Kong listed companies to inform the Exchange about how their businesses have been affected by the outbreak of coronavirus1. Most PRC based listed companies have financial year ends on 31 December, and January through March is their busy period for the preparation of annual reports. However, current travel restrictions to and from PRC and Hong Kong have posed huge challenges for external auditors and also valuers, who often need to conduct on-site inspections and management interview for their work.  

Present Values of Lease Payments under the New Standard: HKFRS 16 Leases

HKFRS 16 Leases has become effective since 1 January 2019 and replaced HKAS 17 Leases for lease accounting to specify the principles for recognition, measurement presentation and disclosure of leases. The new standard specifies that individual leases should be considered separately.

Valuation Guidelines for Private Equity and Venture Capital

In response to the increasing demands for building consensus within the valuation industry, various valuation guidelines have been developed to suit different purposes, and to caterdifferent needs. Among them the International Private Equity and Venture Capital Valuation (IPEV) Guidelines and International Valuation Standards (IVS) are two of the most widely adopted standards in the private equity investments and accounting practices respectively.

Due diligence by external consultants plays a crucial role in merger & acquisitions

On 4 July 2019, the SFC of Hong Kong issued the “Statement on the Conduct and Duties of Directors when Considering Corporate Acquisitions or Disposals”, reiterating the importance of independent professional valuations in relation to the fiduciary duties of the directors of public companies in their planned acquisitions or disposals. The authority particularly points out the importance of due diligence, which is an area that many valuation practitioners in Hong Kong do not possess the relevant expertise nor resources to advise and work on.

How venture capitals and private equities value startups

Most startups nowadays are involved in “New Economy” sectors such as fintech, biotech, tele-communications, medicines, shared economies, blockchain, and artificial intelligence.